GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Shiller PE Ratio

Hemagen Diagnostics (Hemagen Diagnostics) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hemagen Diagnostics Shiller PE Ratio Historical Data

The historical data trend for Hemagen Diagnostics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Shiller PE Ratio Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hemagen Diagnostics's Shiller PE Ratio

For the Biotechnology subindustry, Hemagen Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Shiller PE Ratio falls into.



Hemagen Diagnostics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hemagen Diagnostics's E10 for the quarter that ended in Sep. 2012 is calculated as:

For example, Hemagen Diagnostics's adjusted earnings per share data for the three months ended in Sep. 2012 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2012 (Change)*Current CPI (Sep. 2012)
=-0.01/97.6331*97.6331
=-0.010

Current CPI (Sep. 2012) = 97.6331.

Hemagen Diagnostics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200212 -0.040 76.324 -0.051
200303 -0.040 77.716 -0.050
200306 -0.040 77.505 -0.050
200309 -0.010 78.138 -0.012
200312 -0.060 77.758 -0.075
200403 -0.040 79.066 -0.049
200406 -0.070 80.037 -0.085
200409 -0.190 80.121 -0.232
200412 -0.020 80.290 -0.024
200503 -0.020 81.555 -0.024
200506 -0.010 82.062 -0.012
200509 -0.040 83.876 -0.047
200512 0.010 83.032 0.012
200603 0.000 84.298 0.000
200606 -0.010 85.606 -0.011
200609 0.030 85.606 0.034
200612 -0.020 85.142 -0.023
200703 -0.020 86.640 -0.023
200706 -0.010 87.906 -0.011
200709 -0.010 87.964 -0.011
200712 0.050 88.616 0.055
200803 0.000 90.090 0.000
200806 0.000 92.320 0.000
200809 -0.020 92.307 -0.021
200812 -0.010 88.697 -0.011
200903 -0.010 89.744 -0.011
200906 -0.020 91.003 -0.021
200909 -0.010 91.120 -0.011
200912 -0.010 91.111 -0.011
201003 0.000 91.821 0.000
201006 0.000 91.962 0.000
201009 0.000 92.162 0.000
201012 -0.010 92.474 -0.011
201103 -0.020 94.283 -0.021
201106 0.000 95.235 0.000
201109 -0.020 95.727 -0.020
201112 -0.020 95.213 -0.021
201203 -0.020 96.783 -0.020
201206 -0.010 96.819 -0.010
201209 -0.010 97.633 -0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hemagen Diagnostics  (OTCPK:HMGN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hemagen Diagnostics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines